Marc Nazare

Prof. Dr. Marc Nazare, Group Leader Medicinal Chemistry at the Leibniz Research Institute for Molecular Pharmacology FMP, Berlin, Germany. Marc Nazare studied chemistry at the Karlsruhe Institute of Technology (KIT) and obtained his PhD in organic chemistry in 1999 under the guidance of Prof. Herbert Waldmann working on a natural product total synthesis. He started his career in the pharmaceutical industry at Sanofi-Aventis in Frankfurt, as a medicinal chemist and project leader. Over the years he has been working on kinase-, GPCR-, protease- and ion channel projects covering both early and late stage research. Marc Nazare contributed to several clinical candidates of Factor Xa inhibitors and P2Y12 antagonists programs for the treatment of thrombosis. In 2013, he joined the Leibniz Research Institute for Molecular Pharmacology FMP to establish the medicinal chemistry group in the chemical biology department. His research interest is focused on the structure-based design and optimization of chemical probes and imaging tools for chemical biology. He is co-author of more than 150 research publications and patent applications.